We observed that while the IC50 was unaffected between the two populations, the ability of the Syk inhibitor to achieve IC75 and greater was impaired in whole blood from RA patients, suggesting that Syk-independent mechanism(s) were influencing the ability of PRT062607 to suppress B-cell activation (Fig. 1B). The gene discussed is SYK; the disease is rheumatoid arthritis.